Skip to main content
Headway

Compliance and documentation

How to use the Geriatric Depression Scale (GDS)

Learn about scoring bands, population-specific cut-offs, and the versions worth using.

November 13, 2026

By Ryan DeCook, LCSW • Clinically reviewed by Alyssa Peechatka, Ph.D.

12 min read

By Ryan DeCook, LCSW • Clinically reviewed by Alyssa Peechatka, Ph.D.

What to know

1

The Geriatric Depression Scale, or GDS, screens for depressive symptoms specifically in older adults. It identifies who needs further assessment rather than establishing a diagnosis.

2

Each depression-indicating response earns one point, including “no” answers on reverse-scored items. Cutoffs vary by population and version. The original authors did not establish one definitive threshold.

3

A positive screen requires a diagnostic interview, separate suicide-risk assessment, and clear documentation naming the GDS version, score, interpretation, and follow-up actions taken.

Understanding the GDS

Early in my career, I worked with older adults whose depression was tangled up with medical illness. I wish I’d known about the Geriatric Depression Scale (GDS) then.

It’s free, fast, and deliberately leaves out the physical symptoms that blur depression and illness in later life. But clinicians can get tripped up on several things: reverse-scored items, cutoffs that shift by population, and no built-in protocol after a positive screen. This guide covers those common mistakes in depression screening for older adults with the GDS, from administration through documentation.

What is the Geriatric Depression Scale (GDS)?

The Geriatric Depression Scale (GDS) is a self-report screening instrument designed to detect depressive symptoms in older adults, typically ages 55 and older. It’s widely used across community, primary care, hospital, and long-term care settings.

  • Origin and purpose: The GDS was developed in 1982 by Yesavage and colleagues as a 30-item scale validated against Research Diagnostic Criteria and the Hamilton Rating Scale for Depression, specifically for rating depression in the elderly.
  • Why somatic items were excluded: The developers tested physical-symptom questions, but these correlated less strongly with overall depression scores and were dropped, which also reduced overlap with medical illness common in later life.
  • Format and recall window: Clients answer yes-or-no questions based on how they have felt over the past week.
  • Long form and short form: The original has 30 questions. In 1986, Sheikh and Yesavage created a 15-item short form version, keeping the items most strongly associated with depressive symptoms. Several additional shorter forms exist (10, 5, and 4 items), however these are less sensitive and may produce false negatives.
  • Screening only: A score at or above the cutoff threshold prompts a deeper diagnostic interview. It does not establish a diagnosis by itself.

Geriatric Depression Scale short form (GDS-15): Scoring key

The GDS-15 asks about how an older adult has felt over the past week, including life satisfaction, interest in activities, boredom, mood, fears, helplessness, memory concerns, self-worth, energy, and hope for the future. It also explores preferences for staying home and perceptions of how one’s circumstances compare with others’.

The client answers yes or no based on how they’ve felt over the past week. The scale can be self-completed or read aloud.

Each depression-indicating response earns one point. Pay particular attention to reverse-scored items: five questions earn a point for “no,” rather than “yes.”

Scoring groupItem numbersResponse earning 1 point
Regular-scored2, 3, 4, 6, 8, 9, 10, 12, 14, 15Yes
Reverse-scored1, 5, 7, 11, 13No

Practice in-network with confidence

Simplify insurance and save time on your entire workflow — from compliance and billing to credentialing and admin.

Talk to a practice consultant

Geriatric Depression Scale long form (GDS-30): Scoring key

The GDS-30 is the original version of the Geriatric Depression Scale. Its additional questions explore experiences such as persistent worries, restlessness, difficulty concentrating, and decision-making.

Ten items are reverse-scored, meaning “no” earns a point rather than “yes.”

Scoring groupItem numbersResponse earning 1 point
Regular-scored2, 3, 4, 6, 8, 10, 11, 12, 13, 14, 16, 17, 18, 20, 22, 23, 24, 25, 26, 28Yes
Reverse-scored1, 5, 7, 9, 15, 19, 21, 27, 29, 30No

How to score the GDS and what each score range means

1. Score the responses: Award one point for each answer indicating depression and zero for the opposite response. Follow the key and account for the reverse-scored items rather than counting every yes. Sum the points for a total of 0–15 or 0–30, depending on the version.

2. Read the severity band: Band boundaries vary across validations. The most widely published bands are:

  • GDS-15: 0–4 normal, 5–8 mild, 9–11 moderate, and 12–15 severe depression.
  • GDS-30: 0–9 normal, 10–19 mild, and 20–30 severe depression.

3. Apply the referral threshold: A conventional GDS-15 threshold is 5 or higher, indicating possible depression and the need for diagnostic evaluation. Some guidance, including HIGN’s, specifies above 5. Yesavage’s team never committed to a single cutoff for every setting, so pick a protocol and follow it consistently.

4. Interpret a low score carefully: A result below the threshold does not override concerning symptoms. Medical illness, bereavement, or a move into residential care can increase concern and indicate clinical assessment despite the lower score.

5. Use the score as a baseline: Repeat the same version over time. Change across multiple screens tells you more than any single score.

GDS cut-off scores by population: Dementia, Parkinson's, and cognitive impairment

Cognitive impairment is the umbrella term. Mild cognitive impairment (MCI) means noticeable memory or thinking changes in someone who still manages daily life independently.

Dementia means the decline now interferes with that independence. It is staged as mild, moderate, or severe, and Alzheimer’s disease is its most common cause. For GDS use, where a client sits on this spectrum matters more than the label.

  • Cognitive impairment: Use the GDS as usual. Most people with MCI can still report their mood reliably. In a Portuguese sample with mild-to-moderate impairment, a GDS-15 cutoff of ≥9 identified 90% of depression cases and correctly screened negative 62% of people without depression.
  • Alzheimer’s and dementia: The GDS gets less trustworthy as dementia progresses, and changing the cutoff won’t fix that. In mild dementia, use it cautiously and add caregiver input. In one primary study, GDS-30 performance in Alzheimer’s disease was too poor to set a useful threshold. A preliminary 10-item adaptation, the GDS-D, reported 92–97% diagnostic accuracy in Alzheimer’s and frontotemporal dementia, but it needs larger studies before it can replace the standard form.
  • Parkinson's disease: The GDS-15 is a strong fit because it largely skips physical symptoms Parkinson’s itself causes. In one small study, a GDS-15 score of 5 or higher identified 88% of people with depression and correctly screened negative 85% of those without it. One analysis suggests the GDS may not capture a single depression construct in Parkinson’s, so confirm with interview.
  • Measurement error: A meta-analysis of 5,876 participants put the GDS-15’s minimal detectable change at about four points. Smaller shifts may just be noise, and a four-point shift doesn’t automatically mean clinically important change.

The bottom line: Start with the standard threshold (5 or higher on the GDS-15). As cognition declines, raise your suspicion rather than the cutoff, bring in what family or caregivers see, and switch to an observer-rated tool once self-report breaks down.

Which GDS version should you use? GDS-30 vs. GDS-15 vs. GDS-10, GDS-5, and GDS-4

  • GDS-30: Choose this original version for research purposes or when consistency with earlier assessments justifies the added burden. In one study, it caught fewer cases and produced more false positives than the GDS-15.
  • GDS-15: This is the practical default for private practice because it balances established evidence with a manageable five- to seven-minute completion time. It is simple to repeat over time to track client trends.
  • GDS-10 and shorter: Consider this version when time or client stamina limits completion. The review found it is an accurate measure of depression, but has a lower overall ability to distinguish depression from nondepression than the GDS-15.
  • GDS-5 and GDS-4: Use these shorter forms when screening time is very limited. Five-question forms identified about 85% of people with depression, while four-question forms identified about 77%. The evidence is thin, and different four- and five-question forms use different items, so don’t treat them as one test.
  • Translations: You can find various language versions through Yesavage and team’s Stanford resource page. Select a translation validated for your population rather than assuming English-language thresholds.

Validity, reliability, and limitations of the GDS

  • Validated performance: At a GDS-15 cutoff of 5 or higher, research found it identified 89% of people with depression and correctly screened negative 77% without it. A large validation study found that the questions worked consistently together (internal consistency 0.80) and scores were reasonably stable over two weeks (test–retest reliability 0.83).
  • Settings and populations: Evidence supports use with older adults in community, social-service, and primary-care settings, including people with chronic illness.
  • No suicidality item: The GDS does not assess suicidal thoughts. A low score does not rule out suicide risk. Assess it directly.
  • No somatic items: Omitting sleep and appetite symptoms reduces overlap with physical illness but leaves important symptoms unexplored. Address them in a full diagnostic assessment.
  • Moderate to severe dementia: Memory and communication difficulties can undermine GDS self-report. In these cases it is often better to use the Cornell Scale for Depression in Dementia, which incorporates caregiver information.
  • Cutoff variability: Accuracy depends on the population and threshold studied, so match your client to the validation sample.

GDS vs. PHQ-9 vs. Cornell Scale: choosing the right depression screener for older adults

  • GDS-15: A practical fit for elderly adults who can reliably describe their feelings. Omitting sleep and appetite questions reduces the influence of physical illness, so those elements do not inflate the score.
  • PHQ-9: This is useful for a mixed-age caseload and routine symptom tracking. Its nine questions cover the last two weeks and align with DSM depression symptoms. It is used widely, but sleep, appetite, and fatigue scores may reflect medical illness as well as depression. Apply clinical judgment to those somatic questions.
  • Cornell Scale for Depression in Dementia: Use this when cognitive impairment makes self-report unreliable. A clinician rates 19 items using patient and caregiver interviews. It requires more coordination and clinical judgment than a self-completed questionnaire.
  • CES-D: The Center for Epidemiologic Studies Depression Scale performs comparably to the GDS in late-life depression. It was developed for population screening and research rather than clinical case-finding. It includes somatic items, and lacks the recognizability of the PHQ-9, so it sees limited use in private practice.
  • Practical pairing for SI assessment: Neither the GDS (no suicide item) nor the PHQ-9 (one item) covers suicide risk on its own. Pair whichever depression screener you choose with a structured tool such as the C-SSRS and direct questions about ideation, intent, plan, and access to means.

What to do after a positive GDS screen: A step-by-step protocol

  1. Conduct a full diagnostic interview: Confirm symptom duration, depressed mood or loss of interest, associated symptoms, and functional impairment against DSM-5-TR criteria. Ask about past mania or hypomania. The GDS flags risk for depression but it does not establish a diagnosis.
  2. Assess suicide risk directly: According to the CDC, suicide rates are significant for geriatric clients, with men aged 75 and older being the highest risk age group. Ask about thoughts of death, suicidal ideation, intent, plans, preparatory actions, and access to means (firearms or medications). Assess past attempts and protective supports. Address immediate safety first, then build a safety plan and follow-up from the assessment.
  3. Rule out medical and pharmacologic contributors: Work with the client’s medical providers to arrange evaluation for thyroid disease, anemia, B12 deficiency, pain, and neurologic illness as indicated. Review medications, including corticosteroids and sedatives, plus any alcohol or substance use.
  4. Differentiate depression from dementia, delirium, grief, and demoralization: Delirium (sudden, fluctuating confusion and poor attention from an underlying medical cause) needs urgent medical evaluation. Grief centers on a loss, while demoralization involves feeling overwhelmed or hopeless about a specific situation. Depression usually develops over weeks and has a more persistent low mood or loss of interest. Each points to a different treatment plan.
  5. Assess functional and social context: Document self-care, medication management, isolation, recent losses, caregiving burden, and care transitions. Obtain collateral history from family members or caretakers when appropriate.
  6. Build the treatment plan and set a re-screening interval: Agree on psychotherapy, medication evaluation, and practical supports. Repeat the same GDS version consistently (for example, every 30 days; every 90 days; etc.). A change of about four GDS-15 points indicates detectable change, though smaller changes may still matter.
  7. Know when to refer: Seek psychiatric consultation for psychosis, suspected bipolar disorder, severe impairment, or treatment resistance. Imminent suicide risk calls for emergency evaluation through an ED or crisis team. Don’t leave the client alone while you arrange it.

How to document GDS results so they hold up with insurers

  • What to record: Capture the instrument by name and version, the raw total score, the interpretation band it falls in, the date of administration, and the method (self-administered vs. clinician-administered, in person or online).
  • Tie the score to medical necessity: Connect symptoms to specific impairment, such as difficulty managing daily tasks, and explain how treatment addresses that impairment.
  • Document the follow-up: Record the diagnostic evaluation and suicide-risk assessment actually performed, findings, and resulting safety or referral actions.
  • Track baseline versus follow-up: Record the initial GDS total as a baseline, then re-administer at defined intervals during treatment. Multiple scores tracked over time build the outcomes narrative that can support continued authorization.
  • Common documentation failures: Replace “screen positive” with the instrument and interpretation. Add missing dates. Explain scores rather than just listing numbers. For reference, see more Headway articles on documentation and compliance.

Note: Headway does not currently have the Geriatric Depression Scale in our wide collection of scales and assessments. But licensed clinicians may use these links for the GDS-15 (short-form) and GDS-30 (long-form).

FAQs about the GDS

Is the GDS free to use?

Yes. The original developer describes the scale as public domain, and source copies are freely available through Yesavage’s Stanford resource site. Check permissions before reproducing it commercially.

What age is the GDS for?

The GDS was developed for older adults, but its research base is not restricted to people aged 65 and older. The original item-development sample included adults over 55. A large later GDS-15 validation study included adults aged 60 and older. There are no universal age limits.

Can clients complete it themselves?

Yes. The GDS can be self-completed, or a clinician can read the questions aloud when vision or reading difficulties make independent completion difficult for the client. Record the administration method and assistance provided in the chart.

Does the GDS diagnose depression?

No. The GDS identifies possible depression, but it does not establish a diagnosis. A score meeting the selected screening threshold should prompt a diagnostic interview examining symptoms, duration, impairment, and alternative explanations.

Does the GDS assess suicide risk?

No. It has no direct suicidality item. Ask directly or apply a standalone risk-assessment tool. Address suicidal thoughts, intent, plans, and access to means, and document the findings and actions taken. A low GDS score should not prevent suicide-risk assessment when symptoms, history, or other clinical concerns warrant it.

Can it be used with clients who have dementia?

Sometimes. The simple yes-or-no format can help people with mild-to-moderate cognitive impairment, but it depends on their ability to understand questions and report their feelings reliably. For moderate-to-severe dementia, the Cornell Scale for Depression in Dementia is often preferred, which combines patient assessment with caregiver information.

How often should it be re-administered?

There’s no universal interval. Space your administrations to fit the treatment plan, and put them far enough apart for change to exceed the GDS-15’s minimal detectable change of about four points.

Is the GDS available in other languages?

Yes. Yesavage’s Stanford resource site provides translations in many languages. However, the site does not guarantee translation accuracy. Choose a version validated for the client’s language and cultural population whenever possible.

How Headway helps your measurement-based care

Headway brings assessments, documentation, credentialing, and billing into one workflow, so you can manage an insurance-based older adult caseload with less administrative work. Though we don’t offer the GDS built-in, we do have a suite of helpful features:

  • Assessments and EHR: Send supported assessments, review results, and schedule repeat screenings in one workflow. Document the results in the integrated EHR.
  • Documentation support: Use progress note templates to organize clinical findings, document medical necessity, and track follow-up alongside billing.
  • Credentialing and payer access: Headway’s insurance credentialing support helps you join available networks, making care accessible to clients who depend on covered services.
  • Payment stability: Payments arrive on a predictable twice-monthly schedule for eligible sessions.
  • Telehealth reach: Built-in telehealth can reduce travel barriers for homebound or mobility-limited clients when remote care is clinically appropriate.
Talk to a practice consultant

This content is for general informational and educational purposes only and does not constitute clinical, legal, financial, or professional advice. All decisions should be made at the discretion of the individual or organization, in consultation with qualified clinical, legal, or other appropriate professionals.

© 2026 Therapymatch, Inc. dba Headway. All rights reserved. No part of this publication may be reproduced without permission.

Compliance and documentation

How to write progress notes

Progress notes are the core piece of documentation a provider should write after each client session, but it’s more than just a record of what happened.